FDA grants priority review to Roche’s polatuzumab vedotin in previously treated aggressive lymphoma Read more
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain Read more
Aucta Pharmaceuticals and Oakrum Pharma Announce Product Development and Commercialization Partnership Read more
Exicure Announces License and Development Agreement with Dermelix Biotherapeutics in Rare Genetic Skin Diseases Read more
Amgen and GSK to present on Regulatory Updates and Patient Safety at Injectable Drug Delivery 2019 Read more
WuXi STA and BioLingus sign exclusive technology and marketing collaboration for sublingual delivery Read more